Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00365482 · ClinicalTrials.gov registry record

Bipolar Disorder in Epilepsy

A clinical trial of Epilepsy and Bipolar Disorder, sponsored by Northwell Health.

Completed
Registry status
102
Enrollment target
1
Study location

NCT00365482 is a study of Epilepsy and Bipolar Disorder that has completed, run by Northwell Health. The registered enrollment target is 102 participants, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00365482, a study of Epilepsy and Bipolar Disorder, has completed, sponsored by Northwell Health.

COMPLETED
Registry status
102 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to find out how often major mood swings occur in patients treated in a specialty epilepsy center.

Study Locations (1)

New York

  • North Shore Long Island Jewish Health System - Great Neck

Trial Details

FieldValue
Enrollment Target 102 participants
Start Date 2006-08
Est. Completion 2011-12

Sponsor

Northwell Health

370 total trials

What the Registry Record Tells You About NCT00365482

The ClinicalTrials.gov registry entry for NCT00365482 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (89% lower). The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Epilepsy appearing as the primary indexed condition, and to 0 interventions.

NCT00365482 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT00365482 about?

NCT00365482 is a clinical study titled "Bipolar Disorder in Epilepsy". The purpose of this study is to find out how often major mood swings occur in patients treated in a specialty epilepsy center.

What is the current status of trial NCT00365482?

This trial is currently completed. The enrollment target is 102 participants. The study started on 2006-08. Estimated completion is 2011-12.

What conditions does trial NCT00365482 study?

This clinical trial studies the following conditions: Epilepsy, Bipolar Disorder.

Who is sponsoring clinical trial NCT00365482?

This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00365482 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Epilepsy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.